It’s been cited as one of the biggest health crises facing the United States and, if solved, the equivalent dollar value of a blockbuster drug. According to the latest statistics from pharmacy benefit manager Express Scripts, poor medication adherence costs the country $317 billion per year, an upgrade from the $290 billion calculated in a study released in 2009 by the New England Healthcare Institute.
With more than half of U.S. online shoppers buying beauty and personal care products online, beauty brands and retailers must embrace multichannel marketing in order to succeed and reach consumers where they are, according to a new study by A.T. Kearney and its Global Consumer Institute.
Being overweight and obesity during adolescence are associated with a disproportionately higher risk for cardiovascular disease risk factors, especially prediabetes and diabetes, according to a study published in the journal Pediatrics.
Men older than 50 years of age are more than twice as likely as women to develop and die from melanoma, yet many men admit to not using sunscreen, and even more report not knowing what skin cancer warning signs to look for, according to the results of a survey released by the Skin Cancer Foundation in partnership with the makers of Banana Boat and Hawaiian Tropic brand sunscreens.
Only about half of U.S. adults received selected preventive services — such as screenings, consultations and prescriptions — from a healthcare professional before 2010, according to a study published last week by the Centers for Disease Control and Prevention.
As health departments across the country report record numbers of pertussis cases, the results of a new survey of American adults released Wednesday revealed that most parents aren't asking adults close to their infants and young children to get an adult whooping cough booster vaccine, even though they do ask them to follow other basic precautions to safeguard their children's health.
When one of Amylin Pharmaceuticals' diabetes drugs is used with mealtime insulin, both Type 1 and Type 2 diabetes patients maintain blood sugar in the normal glucose range on a daily basis, according to two analyses presented at the 72nd Scientific Sessions of the American Diabetes Association.
An investigational insulin being developed by Novo Nordisk significantly reduced the rate of hypoglycemia at night in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented at the 72nd Scientific Sessions of the American Diabetes Association.
More patients are actively looking for and expecting to find mobile health solutions, according to the global Economist Intelligence Unit report, which was commissioned by PricewaterhouseCoopers and released Thursday.